لەلایەن دەستەی نووسەران · Published · Updated
ڕاگەیەنراوە: ٤ تشرینی یەکەم ٢٠٢٦
پەلەداری: پاشبنەما · بەڵگە: بانگەشەی پاڵدراو بە سەرچاوە
ئەوەی سەرچاوەکان دەیسەلمێنن
JFDA and Obeidat supply the rollout description and intended benefits. The platform was not independently tested; faster processing or completed nationwide implementation is not established. No material disagreement was located. The report is explicitly about a trial and limits the Regions Directorate's initial testing to Amman. Midnight UTC is a date-only reporting reference because the page's clock has no explicit UTC offset, not a known launch time.
دوا پشکنینی بەڵگە: ٤ تشرینی یەکەم ٢٠٢٦ ٠٩:١٤ UTC.
٤ تشرینی یەکەم ٢٠٢٦ ٠٩:١٤ UTC — First published with explicit source roles, evidence limitations and representative mapping.
سەرچاوەکان
- Jordan News Agency (Petra) ئاژانسی هەواڵی دەوڵەتی
local reporting of JFDA's trial announcement and director general Rana Obeidat's intended benefits